It is a pharma private limited company based in Nagercoil, Tamil Nadu, India, established in 2007.
2007 | Nagercoil, Tamil Nadu, India | ActivePhrenos Pharma Private Limited, a active private limited company, was established on 14 November 2007 in Nagercoil, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230TN2007PTC065377. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹1.89 M.
It upholds a active non-compliant status. Its leadership includes Neerathalingam Suguna Ramu (Director), Bhaskar Chandrasekaran (Director), Padmanabhan (Director). Past directors included Sughie Jennifer Ravichandar, Carlius Sheela Prakash. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 47/5/2 Nehru Street Nagercoil, Nagercoil, Tamil Nadu, 629001.
U24230TN2007PTC065377
065377
14 November 2007
₹4.00 M
₹1.89 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Phrenos Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neerathalingam Suguna Ramu | Director | 14 Nov 2007 | Current |
| Bhaskar Chandrasekaran | Director | 14 Nov 2007 | Current |
| Padmanabhan | Director | 14 Nov 2007 | Current |
| Ramanujam Vamsi Sreenivas | Director | 14 Nov 2007 | Current |
| Arunachalam Venkateswaran | Director | 14 Nov 2007 | Current |
| Kasi Nadar Kanesalingavelan | Director | 14 Nov 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Mar 2010 | Past |
| Pramod Abcsdd | Director | 24 Mar 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Phrenos Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 15.01% decrease. The company also saw a slight decrease in profitability, with a 8.61% decrease in profit. The company's net worth Soared by an impressive increase of 14.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Phrenos Pharma had a promoter holding of 79.58% and a public holding of 20.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Phrenos Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Phrenos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phrenos Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Phrenos Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
The activity Phrenos Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai. was completed.
Neerathalingam Suguna Ramu was appointed as a Director was appointed as a Director on 14 Nov 2007 & has been associated with this company since 18 years 21 days . was recorded as a recent event.
Progress on Bhaskar Chandrasekaran was appointed as a Director was appointed as a Director on 14 Nov 2007 & has been associated with this company since 18 years 21 days . was documented.
Progress on Padmanabhan was appointed as a Director was appointed as a Director on 14 Nov 2007 & has been associated with this company since 18 years 21 days . was documented.
Ramanujam Vamsi Sreenivas was appointed as a Director was appointed as a Director on 14 Nov 2007 & has been associated with this company since 18 years 21 days . was recorded as a recent event.
The CIN of Phrenos Pharma Private Limited is U24230TN2007PTC065377.
Phrenos Pharma Private Limited is headquartered at 47/5/2 Nehru Street Nagercoil, Nagercoil, Tamil Nadu, 629001.
Phrenos Pharma Private Limited was incorporated on 14 November 2007.
The current directors of Phrenos Pharma Private Limited are
The primary industry of Phrenos Pharma Private Limited is Trade.
Phrenos Pharma Private Limited is unlisted.
The authorized capital of Phrenos Pharma Private Limited is ₹4.00 M, and the paid-up capital is ₹1.89 M.
The compliance status of Phrenos Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX